An Ayurvedic Management of Tumefactive demyelination of Spinal cord w.s.r to Pangu - A Case Report
Abstract
BACKGROUND: Pangu is a disease caused by vitiated Vata. It is described among 80 Vata rogas. The normal role of Vata is to regulate motor and sensory systems, and its imbalance leads to a decline in these functions. Pangu originates in the Kati region, possibly involving Katyasritavata i,e Apana Vayu along with Vyana Vayu. Paraplegia involves the paralysis of the lower extremities. Although weakness in the lower limbs may arise from peripheral nerve or muscle diseases, the terms paraparesis and paraplegia are typically used to describe manifestations resulting from lesions in the dorsal and lumbosacral region of the spinal cord.
OBJECTIVE: To evaluate the impact of Ayurveda treatment, comprising of external Panchakarma therapies and internal medications in management of Pangu (Paraplegia)
METHODOLOGY: Here is case report of patient, 26 years old female presented with complaints of loss of balance while walking and with reduced muscle power and sensation over her both lower limbs, who was diagnosed with Tumefactive demyelinating lesions of spinal cord. She underwent D11 D12 Laminectomy & Subtotal excision of SOL (Space occupying lesions) under GA. Post-surgically weakness of both lower limbs got aggravated, she was unable to walk without support. She was admitted and treated in lines of Pangu.
RESULTS: Significant improvement was observed in complaints of weakness of both lower limbs. Initially Muscle power was 3/5 in right lower limbs, 4/5 in left lower limb. At the time of discharge power was 5/5 and could able to walk without support.
CONCLUSION: This case highlights the potential of Ayurveda Panchakarma therapies and internal medications, as effective interventions in managing Pangu w.s.r to Tumefactive demyelination of Spinal cord.
References
Patriarca L, Torlone S, Ferrari F, et al. Is size an essential criterion to define tumefactive plaque? MR features and clinical correlation in multiple sclerosis. Neuroradiol J 2016; 29:384–389.
Algahtani H, Shirah B, Alassiri A. Tumefactive demyelinating lesions: a comprehensive review. Mult Scler Relat Disord 2017; 14:72–79.
Hu W, Lucchinetti CF. The pathological spectrum of CNS inflammatory demyelinating diseases. Semin Immunopathol 2009; 31:439–453.https://doi.org/10.2214/AJR.20.23226
Charaka: Charaka Samhita Stra sthana Chapter XX; sloka 11 Vidyotini Hindi commentary by Pandit Kasinatha Sastri. The Chowkhamba Sankrit series Office, Varanasi.
Vagbhata: Astanga Hrdaya ((moolam) Sutra Chapter 12; sloka 9 Chowkhamba Sanskrit Series Office, Varanasi, 1956.
a) Sushruta; Sushruta Samhita Nidana Chapter 1; Sloka, Ayurveda tatwa Sandipika commentary of kaviraj Dr. Ambikadatha Sastri 2nd edition ed. 1968. Chowkhamba Sanskrit series Office, varanai
(b). Vaghbata; Astanga Hrdaya (moolam) Nidana Chapter XV; sloka 44-45 Chowkhamba sankrit Series Office, Varanasi, 1956
a) Vagbhatacharya, Shastri Ambikadutta, editor. Rasaratnasamuchaya, 9thedition, Varanasi, Chaukambha Amarabharati Prakashan, 2003.
b) Gobinddas, Bhaishajya, ratnavali, Balrogadhikar 132th Shloka. 18th ed. Varanasi: Chaukhambha Sanskrit Sansthan.
Shri Govinda Dasji. (2017) Bhaisajya Ratnavali Vol 2. Varanasi: Chaukhambha Sanskrit Sansthan; Chapter26 vatavyadhi chikitsa, shloka; 205-208.
Siddhi Nidan Mishra, Bhaishajya Ratnavali of Kaviraj Govind das Sen, Chaukhambha Surbharati Prakasha, 2009; Vatavyadhi Rogadhikara, Shloka no – 502-505.
Sahasrayoga Edited by – Shri K. V. Krishnan Vaidyan et.al, Published by Vidyarabham Publishers, Kashaya Yoga Prakarana, Aleepy, 23rd edition April 2000.
Vaghbata; Astanga Hrdaya (moolam) Nidana Chapter 15; sloka 9-10 Chowkhamba sankrit Series Office, Varanasi, 2005
